Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing (Q34331439)

1 August 2017

1 reference

title

Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing (English)

1 reference

1 August 2017

0 references

Pereira J

1

1 reference

1 August 2017

Lawlor P

2

1 reference

1 August 2017

Vigano A

3

1 reference

1 August 2017

Dorgan M

4

1 reference

1 August 2017

Bruera E

5

1 reference

1 August 2017

1 August 2001

1 reference

Journal of Pain and Symptom Management

1 August 2017

1 reference

1 August 2017

22

1 reference

1 August 2017

2

1 reference

1 August 2017

672-687

1 reference

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Palliative care in a cancer center: Results in 1984 versus 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Individual variability in the response to different opioids: report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Opioid hyperexcitability: the application of alternate opioid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Pharmacologic treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Methadone in cancer pain management: individualize dose and titrate to effect

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

The Relative Potency between High Dose Oral Oxycodone and Intravenous Morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Morphine kinetics in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Explanation for potency of repeated oral doses of morphine?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Morphine and oxycodone hydrochloride in the management of cancer pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Dose-ranging study of oxycodone for chronic pain in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Controlled-release oxycodone and morphine in cancer related pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

A comparison of morphine, pethidine and fentanyl in the postsurgical patient-controlled analgesia environment.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

A comparison of subcutaneous morphine and fentanyl in hospice cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

Relative Analgesic Potencies of Morphine and Hydromorphone in Postoperative Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

The treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900294-9

7 January 2021

10.1016/S0885-3924(01)00294-9

Identifiers

DOI

1 reference

1 August 2017

1 reference